Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 299 (RNA5SP299)

Target
RNA5SP299
Molecular classification
Pseudogene, Other
01

Overview

RNA, 5S ribosomal pseudogene 299 (RNA5SP299) is a non-coding RNA sequence classified as a pseudogene of the functional 5S ribosomal RNA gene[2]. It does not produce a functional 5S rRNA product, which in the canonical form is a structural and functional component of the large ribosomal subunit involved in protein synthesis[1][2]. Pseudogenes like RNA5SP299 may be transcribed but do not contribute to normal ribosomal function, and most have no known biological activity. Recent studies suggest some pseudogenes can play regulatory roles in gene expression, particularly in cancer biology, but there is no direct evidence of such a function for RNA5SP299[4]. Summary of key points: - RNA, 5S ribosomal pseudogene 299 is a pseudogene with no protein product and no known role as a therapeutic target. - Its canonical function (as 5S rRNA, not the pseudogene) is as a ribosomal RNA structural component, but the pseudogene variant (RNA5SP299) is biologically inactive. - No drugs, biomarker roles, or safety concerns are associated with RNA5SP299 directly. - Pseudogenes can have emerging relevance as regulators of gene expression or biomarkers in cancer, but this remains a general observation rather than a specific fact about RNA5SP299[4].

Other names
RN5S299RNA 5S ribosomal pseudogene 299RNA5SP299RNA, 5S ribosomal 299
02

Mechanism of action

None

03

Biological functions

None known (as a pseudogene)
04

Disease associations

Other
05

Safety considerations

None
06

Interacting drugs

None
07

Biomarkers

None specific

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 299 (RNA5SP299).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 299 (RNA5SP299).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call